Amphotericin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-365

This is a chart showing the mean change in creatinine levels in mg/dL over a period of 3 weeks for two groups of individuals. One group received Amphotericin B Liposome for Injection at a dosage of 3 mg/kg/day (with a sample size of 343), while the other group received Amphotericin B at a dosage of 0.6 mg/kg/day (with a sample size of 344).*

Amphotericin B Liposome for Injection is a sterile, nonpyrogenic, and single-dose vial drug that is to be used for intravenous infusion only. It is important to note that this drug cannot be interchanged or substituted on a milligram per milligram basis with other Amphotericin B products. The drug must be reconstituted and further diluted before usage. The drug is preservative-free and needs to be discarded if there is any unused portion. The usual dosage details are mentioned in the package insert, which should be referred to while using the drug. The drug is distributed by Eugia US LLC, with the company's address as 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520.*

Amphotericin B Liposome for Injection is a sterile, nonpyrogenic drug used for intravenous infusion only. It contains Amphotericin B liposome as an active ingredient and does not have interchangeable or substitutable mg per mg basis with other Amphotericin B products. It requires reconstitution and dilution and comes in one single-dose vial along with a package insert and a 5-micron filter. It is distributed by Eugia US LLC and must be stored up to 25°C (77°F) temperature. The vial stopper does not contain natural rubber latex. The text provides detailed information about the drug, its preparation, dosage, and storage.*